Search

Your search keyword '"Pastori, Claudia"' showing total 24 results

Search Constraints

Start Over You searched for: Author "Pastori, Claudia" Remove constraint Author: "Pastori, Claudia" Database MEDLINE Remove constraint Database: MEDLINE
24 results on '"Pastori, Claudia"'

Search Results

1. The longitudinal characterization of immune responses in COVID-19 patients reveals novel prognostic signatures for disease severity, patients' survival and long COVID.

2. Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms.

3. Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis.

4. Profiling Antibody Response Patterns in COVID-19: Spike S1-Reactive IgA Signature in the Evolution of SARS-CoV-2 Infection.

5. HIV-1 Env Does Not Enable the Development of Protective Broadly Neutralizing Antibodies in an Experimental Autoimmune Encephalomyelitis Mouse Model.

6. Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1-infected patients.

7. Virological and Serological Discordant Profiles in COVID-19 Pneumonia: Two Atypical Clinical Cases.

8. Humoral Immune Responses in COVID-19 Patients: A Window on the State of the Art.

9. The Abrogation of Phosphorylation Plays a Relevant Role in the CCR5 Signalosome Formation with Natural Antibodies to CCR5.

10. The Role of Natural Antibodies to CC Chemokine Receptor 5 in HIV Infection.

11. Induction of Antihuman C-C Chemokine Receptor Type 5 Antibodies by a Bovine Herpesvirus Type-4 Based Vector.

12. M48U1 and Tenofovir combination synergistically inhibits HIV infection in activated PBMCs and human cervicovaginal histocultures.

13. Class B β-arrestin2-dependent CCR5 signalosome retention with natural antibodies to CCR5.

14. GM-3 Lactone Mimetic Interacts with CD4 and HIV-1 Env Proteins, Hampering HIV-1 Infection without Inducing a Histopathological Alteration.

15. ERK1-Based Pathway as a New Selective Mechanism To Modulate CCR5 with Natural Antibodies.

16. Synergy in monoclonal antibody neutralization of HIV-1 pseudoviruses and infectious molecular clones.

17. Spontaneous control of HIV-1 viremia in a subject with protective HLA-B plus HLA-C alleles and HLA-C associated single nucleotide polymorphisms.

18. Induction of HIV-blocking anti-CCR5 IgA in Peyers's patches without histopathological alterations.

19. A nonparametric procedure for defining a new humoral immunologic profile in a pilot study on HIV infected patients.

20. Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women.

21. Two amino acid substitutions within the first external loop of CCR5 induce human immunodeficiency virus-blocking antibodies in mice and chickens.

22. Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells.

23. Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression.

24. Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41.

Catalog

Books, media, physical & digital resources